Waterloo-based Intellijoint Surgical has just announced that it’s signed a distribution agreement with UK-based Corin Group, which works on orthopaedic solutions.
“We are delighted to partner with such a progressive company as Intellijoint Surgical, and are excited about our future collaboration,” said Russ Mably, Corin’s Chief Operating Officer. “This partnership will further strengthen our market leading position in functional implant positioning with our existing OPS Technology (Optimized Positioning System), and underlines our commitment to continue to invest in Personalized Procedural Innovation.”
The distribution agreement gives Corin Group distribution rights for Intellijoint’s flagship product, the Intellijoint HIP. The product recently received FDA clearance and allows surgeons working on restoring hip joint function with intraoperative measurements. In turn, this enables establishment of cup position, equalization of leg length, and restoration or maintenance of offset and joint centre of rotation.
The partnership will also open up channels for co-development between the two companies.
“We are pleased to partner with Corin to offer intellijoint HIP to surgeons in Australia. The broader capability of Corin’s organization and their commitment to innovation will expand access to the latest
technology available for 3D surgical measurement to the growing Australian hip replacement market
where surgeons currently perform about 45,000 procedures annually,” said Armen Bakirtzian, Chief Executive Officer and Co-founder of Intellijoint Surgical. “We look forward to the beginning of a meaningful relationship between our two companies and are excited about future opportunities.”
